Adagio Medical Holdings, Inc. ADGM

Insider Buys alert about insiders buying in the last 12 month

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
P/E ratio 0.00 0.00
P/S ratio 27.19 0.00
P/FCF ratio 0.00 0.00
P/Operating CF (2.30) (1.17)
P/B ratio 0.82 0.00
Price to Tangible BV 0.00 0.00
EV/Sales 22.53 0.00
EV/EBITDA 0.00 0.00
EV/Operating CF (0.46) (0.34)
EV/FCF (0.44) (0.34)
Quick Ratio 2.08 2.66 0.03 0.01 ‡‡‡‡‡ ‡‡‡ ‡‡‡
Current Ratio 2.44 3.27 0.11 0.02 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Debt/EBITDA (0.19) 0.09 0.05 (0.03) ‡‡‡‡‡ ‡‡‡ ‡‡‡
Debt/Assets 48.64% 33.18% 2.10% 0.08% ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Debt/Equity 1.70 0.81 0.00 (0.01) ‡‡‡ ‡‡‡ ‡‡‡
Asset Turnover 0.00 0.02 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡
Operating CF/Net income 0.76 0.39 0.70 (0.45) ‡‡‡‡‡ ‡‡‡ ‡‡‡
Capex/Depreciation (0.39) (0.05) (0.62)
Depreciation/Fixed assets 0.63 16.18 0.37
Interest Coverage 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡
ROE (155.25%) 133.87% 52.02% (11.27%) ‡‡‡‡‡ ‡‡‡ ‡‡‡
ROA (54.71%) (271.53%) (46.14%) 0.71% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
ROIC (83.74%) (341.51%) 0.00% 0.00% ‡‡‡ ‡‡‡ ‡‡‡
Cash ROIC (40.65%) (55.54%) 69.54% 5.76% ‡‡‡‡‡ ‡‡‡ ‡‡‡
Return on Tangible Assets (187.42%) (383.90%) 90.34% (17.43%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Accounts Receivable Turnover 11.36 0.00
Accounts Payable Turnover 0.35 0.99 0.67 0.00 ‡‡‡ ‡‡‡ ‡‡‡
Inventory Turnover 0.32 1.13 0.00
Average Days of Receivables 21.22 86.38
Average Days of Payables 577.38 312.42 1,070.41 0.00 ‡‡‡ ‡‡‡ ‡‡‡
Days of Inventory on Hand 892.22 282.28 928.43
Research and Development Expense of Revenue 0.00% 2,029.73% 5,133.00%
Selling, General and Administrative Expense of Revenue 0.00% 3,326.08% 3,845.67% 0.00% ‡‡‡ ‡‡‡ ‡‡‡
Intangible Assets out of Total Assets 0.48 0.43 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Share Based Compensation of Revenue 0.00% 106.64% 147.33%
Graham Net Nets (0.19) (5.08)
Graham Number 0.00 0.00
Earnings Yield (8.57%) (0.82%)
Free Cash Flow Yield (190.04%) (312.90%)
Revenue per Share 0.00 0.04 0.39 0.00 ‡‡‡ ‡‡‡
Operating CF per Share (1.15) (1.89) (33.75) (0.13) ‡‡‡‡‡ ‡‡‡ ‡‡‡
Capex per Share (0.02) (0.11) (0.45) 0.00 ‡‡‡ ‡‡‡
Free Cash Flow per Share (1.17) (2.00) (34.20) (0.13) ‡‡‡‡‡ ‡‡‡ ‡‡‡
Cash per Share 1.03 1.32 1.82 0.02 ‡‡‡‡‡ ‡‡‡
Shareholders Equity per Share 0.75 1.28 (53.36) (2.31) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Interest Debt per Share 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡
Book value per Share 0.75 1.28 (53.36) (2.31) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Free Cash Flow (19.39) (31.11) (25.99) (0.49) ‡‡‡‡‡ ‡‡‡ ‡‡‡
Working Capital 11.85 17.59 (41.99) (6.12) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capital Expenditures (0.37) (1.65) (0.34)
Net Current Asset Value (10.77) (3.19) (42.19) (160.27) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Receivables 0.05
Average Payables 1.96 3.34 1.95 0.12 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Inventory 2.12 2.94
Average Assets 45.85 27.64 79.30 151.10 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Common Equity 16.16 (56.06) (70.33) (9.47) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
EV/EBIT 0.00 0.00
Capex to Sales 0.00 2.74 1.13
Net Profit Margin 0.00% (12,465.28%) (12,196.67%) 0.00% ‡‡‡ ‡‡‡ ‡‡‡
Price to Operating Income 0.00 0.00